Variability of metabolite yield using STEAM or PRESS sequences in vivo at 3.0 T, illustrated with myo‐inositol
Open Access
- 29 March 2005
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 53 (4), 760-769
- https://doi.org/10.1002/mrm.20434
Abstract
Using as an example the myo‐inositol (mI) band at ∼3.6 ppm in the proton spectrum from brain, an evaluation is presented that highlights the difficulties of quantifying metabolites with strongly coupled spins with either STEAM or PRESS and demonstrates some advantages of prospective sequence analysis when measuring their concentrations. The analysis emphasizes the variation in coupled‐spin signal yield and lineshape, compared with that of uncoupled singlets such as N‐acetylaspartate, a variation that differs from one metabolite spin system to another. This difference in variation between a target metabolite (e.g., mI) and its contaminating background metabolites (e.g., glutamate and taurine, etc.) is shown to provide in certain circumstances a substantial reduction in background contamination (both metabolite and macromolecule) while maintaining sufficient signal‐to‐noise ratio for precise quantification. For example, sequence times are demonstrated, both for STEAM and for PRESS, that, relative to the short echo‐time sequences typical in the literature, enhance the signal to metabolite background of the 3.6‐ppm band of mI by factors of 1.7 and 1.3, respectively, essentially eliminate the macromolecular baseline, and yet in vivo retain an S/N ∼ 10 in both cases. Magn Reson Med 53:760–769, 2005.This publication has 34 references indexed in Scilit:
- Strategy for the spectral filtering of myo‐inositol and other strongly coupled spinsMagnetic Resonance in Medicine, 2004
- Response of metabolites with coupled spins to the STEAM sequenceMagnetic Resonance in Medicine, 2001
- Proton NMR chemical shifts and coupling constants for brain metabolitesNMR in Biomedicine, 2000
- Role of Increased Cerebral myo‐Inositol in the Dementia of Down SyndromeMagnetic Resonance in Medicine, 1995
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993
- Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; Myo‐inositol and related metabolitesNMR in Biomedicine, 1991
- Assignment of resonances in the 1H spectrum of rat brain by two‐dimensional shift correlated and j‐resolved NMR spectroscopyMagnetic Resonance in Medicine, 1991
- Inositol phosphates and cell signallingNature, 1989
- Segmentation of MR Brain Images into Cerebrospinal Fluid Spaces, White and Gray MatterJournal of Computer Assisted Tomography, 1989
- Localized proton spectroscopy using stimulated echoesJournal of Magnetic Resonance (1969), 1987